CLOSE
Precision Medicine - Training Session
Organizer : KyuBum Kwack (Cha University, Korea) & InSong Koh (Hanyang University, Korea)
| Illumina Platform : October 27 (Fri) 13:10 - 15:40 |
Preview Room (Rm# 512)
Chair : InSong Koh (Hanyang University, Korea) |
| 13:10 - 14:10 |
-
Talk 1
-
Thomas Patrick Klemm (Illumina)
-
A new era of next generation sequencing technology, From Panel Sequencing to Whole Genome Sequencing
|
| 14:15 - 15:00 |
-
Talk 2
-
Woojung Shin (Illumina)
-
Illumina Targeted Panel Sequencing and Applications
|
| 15:00 - 15:40 |
-
Demonstration and Tutorial
-
Gabriel Kolle (Illumina)
-
Bioinformatics and Demonstration
|
** Some part of the session will be proceeded in Korean.
** Bringing one’s own Laptop is recommended.
<Program Details>
Talk 1
A new era of next generation sequencing technology, From Panel Sequencing to Whole Genome Sequencing
Genomics is a striking buzz word in today's scientific and business discussions. Even more amazing is the outreach it has already shown into the daily news and people’s personal lives, by changing the outcome of infectious pandemics, pregnancies, cancer therapies and helping new-borns and young children with inherited diseases to overcome previously unsurmountable hurdles in human history. With the genomics field evolving at light speed, innovation is key to keep this development alive. Illumina is constantly improving their products and widening the portfolio to give researchers and clinicians access to new information in a multitude of applications. It is crucial to stay updated on new releases and developments to achieve the best results in studies looking at genetic content and variation. Here we will discuss how cutting-edge research is driving single cell research, epigenetics and large-scale population studies, using next generation sequencing (NGS) and array technology, to discover new findings and therefore paving the way to change in how we will practice medicine in the future. Illumina is playing a crucial role in this transformation being the market leader and following a single vision: To improve human health by unlocking the power of the genome!
Thomas Patrick Klemm (Illumina)
After graduating from the University of Tuebingen (Germany) in bioinformatics and biochemistry in 2009 Thomas undertook an appointment at Duke-NUS Graduate Medical School Singapore in Professor Terri Young's and Steve Rozen's laboratory in 2010 where he was involved in exome data analysis for hereditary diseases and oncology. In August 2012, he joined Illumina Singapore as Sequencing Segment Manager for Singapore, SEA and India. In 2014, he added responsibility for the ANZ region as well as all distributor countries in Asia, including South Korea, managing the whole product portfolio as a Senior Sales Specialist. Since August 2017, Thomas has moved into the focused role of Senior Human Genotyping Specialist, managing the whole human microarray portfolio across the region, reviving the technology use and driving adoption in new markets in Asia Pacific.
Talk 2
Illumina Targeted Panel Sequencing and Applications
The new era of the NGS sequencing is empowering a rapid change of how we utilize this revolutionary technology. Especially targeted resequencing is enabling deep and accurate interrogation of the genomic regions for SNV, in del, homopolymer, and CNV. During this presentation, how this new technology can enable not only determining DNA and RNA sequences in the basic research but also applying it to the clinical translational research and in vitro diagnosis. Illumina is the leader in all these areas in Korea and around the world.
Woojung Shin (Illumina)
Illumina Korea Senior Field Application Scientist Leader
